What Is Cyproterone Acetate?

Drug Name: Cyproterone Acetate Drug Alias: Sepron Androcur English Name: cyproterone acetate Drug Description: Tablet: 50mg / tablet. Main components: No traits: No functional indications to reduce male libido's perverted sexual desire; inoperable prostate cancer; female severe virilization signs: such as very severe hirsutism, severe androgen-dependent hair loss, and eventually cause baldness Severe androgenic alopecia), often accompanied by severe acne and / or seborrhea.

Cyproterone acetate

Drug name: Cyproterone acetate Drug alias:

[English name] Cyproterone Acetate [Other names]

[Main ingredients] Cyproterone acetate

[Chemical name] 6-chloro-1, 2-methylene-3,20-diprogesterone-4,6-diene-17-

[

1. It should be applied under the guidance of a doctor, and a comprehensive physical examination should be performed before medication.

2. For long-term use, a physical examination should be performed every six months to check the thickness of the breast and endometrium.

3. If the first occurrence of migraine and frequent headaches; sudden visual or hearing disorders; the first symptoms of thrombophlebitis or thromboembolic disease; jaundice, systemic pruritus, and significant increase in blood pressure should be discontinued immediately.

4. Pregnancy, breastfeeding, liver disease, history of jaundice or persistent pruritus during pregnancy, history of herpes during pregnancy, Dubin-Johnson syndrome, Rotor syndrome, previous or existing liver tumors (not due to metastatic prostate cancer), Consumable diseases (except for inoperable prostate cancer), severe chronic depression, previous or existing thromboembolic conditions, severe diabetes with vascular changes, sickle cell anemia are contraindicated. Patients with prostate cancer have a history of thromboembolism, sickle cell anemia, or severe diabetes with vascular changes. Before applying this drug, the pros and cons must be carefully weighed for each case. Patients with a high degree of concentration in their occupations (such as drivers and machine operators) should be used with caution. This medicine can cause fatigue, diminished energy, and may affect the ability to concentrate. The drug's libido-reducing effect can be weakened by the anti-suppressive effect of alcohol. The drug should not be given until the end of puberty, as its adverse effects on physical growth and the unstable endocrine function axis cannot be ruled out. During treatment, liver function, adrenal function and red blood cell count should be checked regularly. Diabetes patients should be used with caution, and the need for oral anti-diabetic drugs or insulin can vary. Like other sex steroid hormones, individual cases report benign and malignant liver changes. In rare cases, liver tumors can cause life-threatening intra-abdominal bleeding. Therefore, when abnormal epigastric discomfort occurs and cannot disappear by itself in a short period of time, appropriate diagnosis and treatment should be performed. Before the start of treatment, a thorough systemic and gynecological examination (including breast and cervical cytology smears) should be performed. Women of childbearing age must exclude pregnancy. If during the combination treatment a small amount of irregular bleeding occurs within 3 weeks of taking the medication, the medication should not be stopped. However, if there is excessive bleeding, the necessary tests should be performed. After a few weeks of use, the drug gradually restricted male fertility. This ability can be restored months after stopping treatment. In men, it can cause breast enlargement (sometimes with nipple tenderness), which usually subsides after stopping treatment. For women, combined therapy can inhibit ovulation, so infertility and breast bloating may occur. In some cases, hepatic impairment has occurred when treated with high doses of this drug, and some have reported severe impairment. Fatigue, loss of energy, occasional temporary irritability or emotional depression can occur, and weight changes can occur. May occasionally cause shortness of breath. In rare cases, thromboembolism has been reported to be associated with the use of this drug. However, causality seems uncertain.